Table of Contents
PISCATAWAY, N.J. – Camber announced that the company is fully prepared to meet the new Drug Supply Chain Security Act (DSCSA) requirements, ensuring enhanced traceability, verification, and safety across the pharmaceutical supply chain. With robust systems for Verification Routing Services, Exception Handling, Master Data Management, and Inventory Control, Camber integrates advanced technology to maintain compliance and uphold the highest product safety standards.
• Status: 100% fully aggregated from bottle to pallet.
• Testing: Completed extensive testing with multiple customers, achieving a 95-100% success rate.
• VRS: Utilizing TraceLink for product authentication since November 2022.
• Handling: Currently conducting EPCIS data testing with all customers.
• GTIN Data: Global Trade Item Numbers are provided to all participating customers via HDAs.
"Camber is fully prepared for DSCSA compliance by November 2024. We are increasing our inventory to support our customers during the transition period if their other suppliers are not fully compliant," the company said
Learn more about the Drug Supply Chain Security Act (DSCSA) on the FDA’s website.
